Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Axio is a multi-ingredient dietary supplement developed by LifeVantage, marketed as a "smart energy" or nootropic drink mix designed to enhance mental focus, clarity, and mood. The product is formulated with a blend of bioactive ingredients, including caffeine (in the regular version), B vitamins (B3, B6, B12), magnesium, and botanical extracts such as green tea, pine bark, and quercetin. Its mechanism of action is multifaceted: caffeine acts as an adenosine receptor antagonist to increase alertness and reduce fatigue; L-theanine modulates neurotransmitters like glutamate and GABA to promote a state of relaxed alertness; and botanical antioxidants provide neuroprotective effects by mitigating oxidative stress. Axio is often positioned within the "biohacking" community as a cognitive enhancer that provides sustained energy without the "crash" associated with traditional high-sugar energy drinks.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Axio.